Search clinical trials for: Mature T-Cell Lymphoma

Total 10853 results

University of Cologne

Completed

Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL)

Lymphocyte Predominant Hodgkin´s Lymphoma (LPHD)

Germany
Grupo Oncológico para el Tratamiento y el Estudio...

Unknown

Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma (GOTEL-FL1LC)

Follicular Lymphoma

Spain
Theradex

Unknown

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Lymphoma

United States, Canada
University of Cologne
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; German Hodgkin...

Terminated

Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma

Hodgkin Disease

Germany
Otsuka Beijing Research Institute
Otsuka Pharmaceutical Co., Ltd.

Unknown

Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Non-Hodgkin's Lymphoma(NHL) | Multiple Myeloma(MM)

Hong Kong
French Innovative Leukemia Organisation

Completed

Liposomal Anthracyclin in the Treatment of Elderly ALL

Acute Lymphoblastic Leukemia

France
German Cancer Research Center
Heidelberg University

Completed

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

Gastrointestinal Neoplasms | Hodgkin Disease | Weight Loss | Non-Hodgkin Lymphoma | Bronchial Carcinoma

Germany
Pfizer

Completed

A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections

Invasive Fungal Infections

China
University of Aarhus

Completed

Laboratory Aspirin Resistance in Diabetics and Non-Diabetics

Drug Resistance

Denmark
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.

Tumors | Non-Hodgkins's Lymphoma

United States
St. Jude Children's Research Hospital

Completed

A Study of Children With Refractory or Relapsed ALL

Acute Lymphoblastic Leukemia

United States
Exelixis

Terminated

Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Dana-Farber Cancer Institute
Sanofi; Brigham and Women's Hospital

Completed

Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of Head and Neck | Advanced Squamous Cell Carcinoma | SSCHN
Tel-Aviv Sourasky Medical Center

Unknown

11C-Acetate PET/CT Non-FDG-Avid Tumors

Carcinoma, Hepatocellular | Lung Cancer | Neuroendocrine Tumors | Thyroid Cancer | Carcinoma, Lobular | Teratoma | GIST | Soft Tissue Sarcomas | Indolent Lymphoma | Uterine Malignancies

Israel
University of Pittsburgh
Biogen

Completed

Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma

Non-Hodgkin Lymphoma

United States
GERCOR - Multidisciplinary Oncology Cooperative...

Unknown

Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

France
Oslo University Hospital
University of Oslo

Unknown

Dietary Intervention in Follicular Lymphoma (KLYMF)

Follicular Lymphoma

Norway
Enzon Pharmaceuticals, Inc.

Terminated

A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma

Lymphoma | Tumors

United States
Amgen

Completed

A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma
Tanox

Unknown

Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma

Hodgkin's Lymphoma

United States
St. Jude Children's Research Hospital

Completed

Large Cell Lymphoma Pilot Study III

Lymphoma, Non-Hodgkin | Lymphoma, Large Cell

United States
St. Jude Children's Research Hospital

Completed

Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma

Lymphoblastic Lymphoma

United States
US Oncology Research
Fred Hutchinson Cancer Center; Chiron Corporation

Terminated

Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
Pfizer

Completed

Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Korea, Republic of, China, Taiwan, Hong Kong
Sanofi

Completed

A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer

Stomach Neoplasms

Colombia
Genitope Corporation

Terminated

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Non-Hodgkin's Lymphoma

United States
University Hospital Freiburg
Boehringer Ingelheim

Terminated

EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye (EAGLE)

Stroke | Visual Acuity | Fibrinolysis | Retinal Artery Occlusion | Hemodilution

Germany, Switzerland, Austria
Madrilenian Group of Cutaneous Lymphomas

Terminated

PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides (MF99)

Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

Spain
Peking University People's Hospital
Peking University; Sanofi

Unknown

Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis

Colorectal Cancer | Resectable Liver Metastasis

China
Eisai Inc.
National Cancer Institute (NCI); Tufts Medical Center; Ligand Pharmaceuticals

Completed

Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

Lymphoma, T-Cell, Cutaneous

United States
Eisai Inc.

Completed

Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary Syndrome

Germany, Canada, United Kingdom, Austria, Russian Federation, United States, Australia, Poland, Switzerland, Netherlands
Eisai Inc.

Completed

Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients

Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Sezary Syndrome

Germany, Canada, Australia, United Kingdom, Austria, Russian Federation, United States, Poland, Switzerland
National Cancer Institute (NCI)

Completed

A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

Lymphoma | Breast Cancer | Neoplasm | Prostatic Neoplasm

United States
National Institute of Dental and Craniofacial Research...

Completed

Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells

Sjogren's Syndrome | Graft vs Host Disease

United States
National Cancer Institute (NCI)

Completed

The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies

Lymphoma | Healthy | Chronic Myeloid Leukemia | Hematologic Neoplasm

United States
National Institute of Diabetes and Digestive and...

Completed

Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas

Neoplasm Metastasis | Zollinger Ellison Syndrome | Islet Cell Adenoma

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

Lymphoma | Carcinoma, Renal Cell | Cancer | Breast Cancer | Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

Evaluation and Natural History of Children With Cancer and AIDS

HIV Infections | Acquired Immunodeficiency Syndrome | Lymphoma | Leukemia | Cancer

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Lymphoma | Breast Cancer | Neoplasm Metastasis | Ovarian Cancer | Kidney Neoplasm

United States
National Cancer Institute (NCI)

Completed

Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma

Lymphoma | Testicular Neoplasms | Breast Neoplasms | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors

Lymphoma, Non-Hodgkin

United States
National Cancer Institute (NCI)

Completed

Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac

Lymphoma, T-Cell, Cutaneous | Leukemia, T-Cell

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma

B Cell Lymphoma

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines

HIV Infections | Lymphoma, Non-Hodgkin | Lymphoma, AIDS-Related

United States
National Cancer Institute (NCI)

Completed

Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy

Neoplasm Metastasis | Breast Neoplasm

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

Lymphoma | Myelodysplastic Syndromes | Myeloid Leukemia | Hematologic Neoplasms | Graft vs Host Disease

United States
National Institute of Allergy and Infectious Diseases...

Completed

Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care

Chronic Granulomatous Disease

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Melanoma | Lymphoma | Renal Cell Carcinoma | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas

Burkitt Lymphoma | Lymphoma, Large-Cell, Diffuse | Lymphoma, Small Noncleaved-Cell

United States
National Cancer Institute (NCI)

Completed

In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients

Lymphoma | Leukemia | Neoplasm | Immunologic Deficiency Syndrome

United States

Search clinical trials for: Mature T-Cell Lymphoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations